IMMUNE RNA: POSSIBLE APPLICATIONS FOR HUMAN CANCERS = ARN IMMUN: APPLICATIONS POSSIBLES DANS LES CANCERS HUMAINSPILCH YH.1972; FRONTIERS RADIAT. THERAP. ONCOL.; SWITZ.; DA. 1972; NO 7; PP. 76-83; BIBL. 26REF.Serial Issue

SPECIFIC MIF RELEASE BY RAT LYMPHOCYTES FOLLOWING INCUBATION WITH SYNGENEIC ANTI-TUMOR IMMUNE RNAWALDMAN SR; PILCH YH.1975; CELL. IMMUNOL.; U.S.A.; DA. 1975; VOL. 18; NO 1; PP. 246-250; BIBL. 18REF.Article

ANTITUMOR ANTIBODY SYNTHESIS IN VITRO INDUCED IN MOUSE SPLEEN CELLS BY SCENOGENEIC IMMUNE RNA.KERN DH; PILCH YH.1978; J. NATION. CANCER INST.; USA; DA. 1978; VOL. 60; NO 3; PP. 599-603; BIBL. 23 REF.Article

CELLULAR CYTOLYSIS IN VITRO: MECHANISMS UNDERLYING A QUANTITATIVE ASSAY FOR CELLULAR IMMUNITY = CYTOLYSE CELLULAIRE IN VITRO: MECANISMES A LA BASE D'UNE EPREUVE QUANTITATIVE POUR L'ETUDE DE L'IMMUNITE CELLULAIREMACPHERSON BR; PILCH YH.1972; J. NATION. CANCER INST.; U.S.A.; DA. 1972; VOL. 48; NO 6; PP. 1619-1627; BIBL. 31REF.Serial Issue

CONVERSION OF NORMAL HUMAN LYMPHOCYTES TO TUMOR-SPECIFIC IMMUNOREACTIVITY BY SCENOGENEIC IMMUNE RNA: BLASTOGENIC RESPONSES TO SOLUBLE TUMOR ANTIGENS.COATES MR; PILCH YH.1977; CANCER IMMUNOL. IMMUNOTHERAPY; GERM.; DA. 1977; VOL. 3; NO 2; PP. 145-152; BIBL. 19 REF.Article

IMMUNOTHERAPY OF HUMAN MALIGNANCIES WITH IMMUNE RNA.DEKERNION JB; RAMMING KP; PILCH YH et al.1977; WORLD J. SURG.; GERM.; DA. 1977; VOL. 1; NO 5; PP. 625-635; ABS. FR.; BIBL. 31 REF.Article

INTRACELLULAR LOCALIZATION OF ANTI-TUMOR IMMUNE RNA.KERN DH; DE KERNION JB; PILCH YH et al.1976; CELL. IMMUNOL.; U.S.A.; DA. 1976; VOL. 22; NO 1; PP. 11-18; BIBL. 13 REF.Article

CONVERSION OF HUMAN LYMPHOCYTES TO ANTITUMOR IMMUNE REACTIVITY BY XENOGENEIC AND ALLOGENEIC IMMUNE RNA DETECTED BY LEUKOCYTE-ADHERENCE INHIBITION TESTSFRITZE D; NAYAK SK; PILCH YH et al.1980; CANCER IMMUNOL. IMMUNOTHER.; ISSN 0340-7004; DEU; DA. 1980; VOL. 9; NO 4; PP. 255-263; BIBL. 45 REF.Article

ENHANCEMENT OF METASTASIS DEVELOPMENT BY BCG IMMUNOTHERAPYCOLMERAUER ME; KOZIOL JA; PILCH YH et al.1980; J. SURG. ONCOL.; ISSN 0022-4790; USA; DA. 1980; VOL. 15; NO 3; PP. 235-241; BIBL. 29 REF.Article

A CONTINUOUS CELL LINE DERIVED FROM A HUMAN PRIMARY CUTANEOUS MELANOMA: MORPHOLOGIC AND KARYOLOGIC PROPERTIESNAYAK SK; DROGEMULLER CR; PILCH YH et al.1980; J. SURG. ONCOL.; ISSN 0022-4790; USA; DA. 1980; VOL. 15; NO 4; PP. 335-344; BIBL. 20 REF.Article

IMMUNE RNA IN THE IMMUNOTHERAPY OF CANCER.PILCH YH; FRITZE D; KERN DH et al.1976; MED. CLIN. N. AMER.; U.S.A.; DA. 1976; VOL. 60; NO 3; PP. 567-583; BIBL. 30 REF.Article

TRANSFER OF TUMOR SPECIFIC IMMUNITY WITH IMMUNE RNA: PROSPECTS FOR THE TREATMENT OF HUMAN CANCER.FRITZE D; KERN DH; PILCH YH et al.1976; KLIN. WSCHR.; DTSCH.; DA. 1976; VOL. 54; NO 18; PP. 851-863; ABS. ALLEM.; BIBL. 3 P.Article

IMMUNE CYTOLYSIS OF HUMAN TUMOR CELLS MEDIATED BY XENOGENEIC IMMUNE RNAPILCH YH; VELTMAN LL; KERN DH et al.1974; ARCH. SURG.; U.S.A.; DA. 1974; VOL. 109; NO 1; PP. 30-34; BIBL. 20REF.Article

QUANTITATION OF CYTOTOXIC ANTITUMOR ANTIBODY IN VITRO : A MICROASSAY WITH 125I-IODODEOXYURIDINE AS A TUMOR CELL LABELFRITZE D; KERN DH; PILCH YH et al.1974; J. NATION. CANCER INST.,; U.S.A.; DA. 1974; VOL. 53; NO 5; PP. 1403-1407; BIBL. 18REF.Article

LYMPHOCYTE POPULATIONS PARTICIPATING IN CELLULAR ANTI-TUMOR IMMUNE RESPONSES MEDIATED BY IMMUNE RNA.KERN DH; CHOW N; PILCH YH et al.1978; J. NATION. CANCER INST.; U.S.A.; DA. 1978; VOL. 60; NO 2; PP. 335-344; BIBL. 1 P. 1/2Article

CHANGING CONCEPTS IN ESTABLISHING THE DIAGNOSIS OF BREAST MASSES.COATES MR; PILCH YH; BENFIELD JR et al.1977; AMER. J. SURG.; U.S.A.; DA. 1977; VOL. 134; NO 1; PP. 77-81; BIBL. 7 REF.Article

KINETICS OF SYNTHESIS AND IMMUNOLOGICALLY ACTIVE FRACTION OF ANTI-TUMOR IMMUNE RNAKERN DH; CHOW N; PILCH YH et al.1976; CELL. IMMUNOL.; U.S.A.; DA. 1976; VOL. 24; NO 1; PP. 58-68; BIBL. 18 REF.Article

IMMUNE CYTOLYSIS OF HUMAN TUMOR CELLS MEDIATED BY XENOGENEIC IMMUNE RIBONUCLEIC ACID: IMPLICATIONS FOR IMMUNOTHERAPYVELTMAN LL; KERN DH; PILCH YH et al.1974; AMER. J. OBSTETR. GYNECOL.; U.S.A.; DA. 1974; VOL. 119; NO 7; PP. 959-965; BIBL. 39REF.Article

IMMUNE CYTOLYSIS OF HUMAN TUMOR CELLS MEDIATED BY XENOGENEIC IMMUNE RNA: IMPLICATIONS FOR IMMUNOTHERAPYPILCH YH; VELTMAN LL; KERN DH et al.1974; SURGERY; U.S.A.; DA. 1974; VOL. 76; NO 1; PP. 23-34; BIBL. 20REF.Article

IMMUNE CYTOLYSIS OF HUMAN TUMOR CELLS MEDIATED BY XENOGENEIC IMMUNE RNA = CYTOLYSE IMMUNITAIRE DE CELLULES TUMORALES HUMAINES PAR VOIE D'ARN IMMUN XENOGENIQUEVELTMAN LL; KERN DH; PILCH YH et al.1974; CELL. IMMUNOL.; U.S.A.; DA. 1974; VOL. 13; NO 3; PP. 367-377; BIBL. 20REF.Article

IMMUNOGENICITY OF CHEMICALLY INDUCED MURINE COLON CANCERSBELNAP LP; CLEVELAND PH; COLMERAUER MEH et al.1979; CANCER RES.; USA; DA. 1979; VOL. 39; NO 4; PP. 1174-1179; BIBL. 31 REF.Article

SEROLOGIC EVIDENCE FOR CROSS-REACTING ANTIGENS IN TWO CARCINOGEN INDUCED MURINE SARCOMASFRITZE D; KERN DH; WALDMAN SR et al.1975; INTERNATION. J. CANCER; SWITZ.; DA. 1975; VOL. 15; NO 1; PP. 116-131; ABS. FR.; BIBL. 1P. 1/2Article

ANTI-TUMOR EFFECT OF SYNGENEIC SPLEEN CELLS TREATED WITH IMMUNE RNA AND TUMOR ANTIGENFUKUSHIMA M; COLMERAUER MEM; NAYAK SK et al.1982; INT. J. CANCER; ISSN 0020-7136; CHE; DA. 1982; VOL. 29; NO 1; PP. 113-117; BIBL. 13 REF.Article

MEDIATION OF CYTOTOXIC IMMUNE RESPONSES AGAINST HUMAN TUMOR-ASSOCIATED ANTIGENS BY ALLOGENEIC IMMUNE RNA.KERN DH; FRITZE D; SCHICK PM et al.1976; J. NATION. CANCER INST.; U.S.A.; DA. 1976; VOL. 57; NO 1; PP. 105-109; BIBL. 20 REF.Article

HUMAN LYMPHOBLASTOID CELLS IN CULTURE REPLICATE IMMUNE INFORMATION CARRIED BY XENOGENEIC RNAVIZA D; BOUCHEIX C; KERN DH et al.1978; DIFFERENTIATION; DEU; DA. 1978; VOL. 11; NO 3; PP. 181-184; BIBL. 15 REF.Article